KOSN
Knobias Clip Report (10-26-2007)
Sunday, October 28th, 2007Rating 3.00 out of 5
[?]Submitted By Knobias ClipReport
KOSN: CEO Comments on Roche’s Termination of Epothilone Collaboration
Roche provided notice that it is terminating its collaboration agreement with Kosan Biosciences Inc. (KOSN) for the development of the Company’s current epothilone anticancer product candidate, KOS-1584, and any other epothilones developed under the collaboration in the field of oncology. […]
